The Market for Next-Generation-Sequencing Neonatal Testing (NGS-NIPT) in China
Next Generation NIPT Sequencing in China estimates the revenues for non-invasive prenatal testing in this emerging market, and generally analyzes the role of next generation sequencing (NGS) in the country. Estimates in this report include revenues for non-invasive prenatal testing using sequencing in China, projections to 2020, market share. Institutions performing NGS and key equipment manufacturers and service providers are discussed.
This report was created as a cooperative project between Kalorama Information and The Freedonia Group, with staff from Freedonia’s Beijing office completing primary and secondary research.